Crossmark

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Crossref DOI link: https://doi.org/10.1038/s41579-022-00731-y

Published Online: 2022-04-27

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dartois, Véronique A. https://orcid.org/0000-0001-9470-5009
Rubin, Eric J. https://orcid.org/0000-0001-5120-962X
License Information

Text and Data Mining valid from 2022-04-27

Version of Record valid from 2022-04-27
More Information

Article History

Accepted: 23 March 2022

First Online: 27 April 2022

Competing interests

: The authors declare no competing interests.